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Abstract 
Aims: To show that an increased correlation between CpGs after selection through an EWAS 
might translate into biased replication results.  
Methods: The NINFEA cohort data were used to calculate pairwise correlation coefficients 
between CpGs selected in three published EWAS. We specified the appropriate replication 
null hypothesis, calculated r-values and Benjamini-Hochberg (BH) FDR p-values. Exposures’ 
random permutations were performed to show the empirical p-value distributions. 
Results: The average pairwise correlation coefficients between CpGs were enhanced after 
selection for the replication (e.g. from 0.14 at genome-wide level to 0.29 among the selected 
CpGs), affecting the empirical p-value distributions and the usual BH-FDR control. 
Conclusions: BH-FDR method might be inappropriate for the EWAS replication phase, and 
methods that account for the underlying correlation need to be used. 
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Introduction 
Recent technological developments have enabled the widespread use of epigenome-wide 
association studies (EWAS) focused on identification of DNA methylation markers of disease 
state and progression and markers of a variety of exposures. Many large projects and some 
consortia have been established to reach a large sample size and allow comprehensive 
epigenetic mapping.  
Although methylation occurs throughout the genome, it is often clustered along a 
chromosome with CpG sites likely being in the same methylation state when they are spatially 
close together [1]. CpG-rich areas, known as CpG islands [2], contain correlated sites with 
similar methylation state. The issue of correlation between nearby loci has been tackled to 
some extent in the EWAS by analyzing together areas with analogous functions. Region 
discovery [3], bump hunting [4], different clustering methods [5,6], or grouping by genomic 
annotations are only some of the strategies proposed in the literature that cope with correlated 
CpG sites. These methods offer biologically interpretable results but replication after the 
discovery phase is not straightforward [7]. 
As well recognized in the context of genome-wide association studies, replication and 
validation of epigenome-wide findings is essential and may be challenging. This task 
traditionally implies testing of few candidate CpG loci identified as top hits in the discovery 
sample, by applying gold-standard experimental methods, such as pyrosequencing, in an 
independent sample. Recently, high-throughput epigenome-wide studies focusing on 
exposures that have extensive impact on DNA methylation identify hundreds or thousands of 
potentially relevant single methylation sites. Replication/validation of these candidates with 
pyrosequencing is not possible in practice. Therefore, we often rely on replication in an 
independent sample with available epigenome-wide data, such as those from large epigenome 
consortia.  
 
 
Under such scenario, it is intuitive that the average pairwise correlation between single sites 
in the large discovery EWAS will be lower than the average pairwise correlation between the 
few hundreds of single sites selected for the replication study. This fact is rarely taken into 
consideration in EWAS replication studies and the analyses in the replication sample may, 
thus, be biased. Benjamini-Hochberg False-discovery rate (FDR) correction [8], which is 
typically used both in the discovery and replication phase of the epigenome-wide studies is 
robust, yet does not take into account the underlying correlation structure. In replication 
studies based on epigenome-wide data, the false-discovery controlling procedure must 
consider an appropriate replicability null hypothesis as, for example, done by be the so-called 
r-value [9]. For what we have said insofar, the robustness of the procedure to the lack of 
independence is much more important for the replication than for the discovery study. 
This article has an illustrative intent. We first show with real data examples that the average 
pairwise correlation between CpG sites increases after selection through an epigenome-wide 
discovery analysis. We then illustrate how this increased correlation may translate into biased 
interpretations of the results in replication analyses, and show the appropriate method for 
replication studies that quantifies the strength of replication taking into account the underlying 
correlation structure [9]. 
Materials 
Literature dataset 
We used findings from three studies assessing DNA methylation in newborns in association 
with three different exposures: i) a study on 6685 children from the Pregnancy and Childhood 
Epigenetics (PACE) consortium that identified 6073 over 464,628 CpG sites whose 
methylation levels were associated with maternal sustained smoking during pregnancy [10]; 
ii) a study on sex differences in DNA methylation in 111 Mexican-American newborns, 
 
 
members of the CHAMACOS study, that identified 3031 over 410,072 CpG site candidates 
located on the autosomal chromosomes [11]; iii) and a study on 1988 newborns from two 
European cohorts that identified 443 over 419,905 CpG site candidates associated with 
maternal plasma folate levels during pregnancy (hereafter referred to as the “maternal plasma 
folate study”) [12]. All these studies involved analyses on DNA methylation from newborn 
blood samples, and they selected CpG sites by using a fixed threshold of Benjamini and 
Hochberg FDR-corrected p-values of 0.05. 
NINFEA replication study 
We retested the selected CpG candidates from the three literature datasets described above, in 
epigenome-wide data coming from the NINFEA birth cohort [13]. The study design was a 
nested case-control study on 72 cases with at least one reported episode of wheezing between 
6 and 18 months of age and 72 controls matched to cases by sex, age at sampling and 
seasonality/calendar year of sampling. In the NINFEA birth cohort saliva samples are 
routinely collected from infants at approximately 6 months of age using a mailed Oragene 
self-collection kit, and in the nested case control study we focused on saliva DNA 
methylation markers of childhood wheezing (data not published). DNA extracted from the 
saliva samples of cases and matched controls was assessed for epigenome-wide methylation 
using the Illumina Infinuim HumanMethylation450 BeadChip. Three cases and three matched 
controls were excluded due to high percentage of missing DNA methylation values, leading to 
a total of 138 subjects available for the analyses. The baseline NINFEA questionnaire is 
completed by mothers during pregnancy and includes questions on sustained smoking in 
pregnancy and intake of folic acid during pregnancy – no information is instead available on 
plasma folate levels. Information on child sex is obtained at the first follow-up questionnaire 
that is completed 6 months after delivery. 
 
 
The Ethical Committee of the San Giovanni Battista Hospital and CTO/CRF/Maria Adelaide 
Hospital of Turin approved the NINFEA study (approval N. 0048362, and subsequent 
amendments), and all the participating mothers gave their informed consent before taking part 
in the study. 
Methods 
Statistical analyses  
NINFEA cases and controls were pooled together. For each selected CpG site – see details 
below – we obtained a methylation percentage (Beta values) from the Illumina Infinuim 
HumanMethylation450 BeadChip and they were converted to M values by a logit 
transformation [14]. After quality control and probes filtering (probes corresponding the SNPs 
inside the probe body and SNPs at CpG sites, cross hybridizing and probes on the sex 
chromosomes) a total of 321,084 probes were available in the NINFEA dataset.  
For each of the three literature datasets (the PACE consortium, the CHAMACOS study and 
the maternal plasma folate study) we retrieved the published selected altered CpG sites that 
were then used in the NINFEA dataset. Due to different probe filtering between the NINFEA 
study and the three literature datasets, there was an incomplete overlap of the top hits. 
All the analyses were performed using RStudio (version 0.99.903).  
The analytical flow is summarized in Figure 1 and described below in details.                                                  
Correlation analysis 
For each of the three groups of selected CpG sites – derived from the three literature examples 
– we estimated the pairwise Spearman correlation coefficients between the CpG site M values 
in the NINFEA replication study. The three distributions of correlation coefficients were 
compared with the distribution of genome-wide pairwise correlation coefficients between 
CpG sites (histograms, summary statistics with the 3rd, 50th and 97th percentiles, F test on 
 
 
homogeneity of variance on Fisher’s zeta transformation [15]). To obtain the genome-wide 
correlation distribution, we calculated the pairwise correlation coefficients between 100,000 
randomly selected CpG pairs among all available CpG sites in the NINFEA data.  
Replication analyses 
Replication of CpG sites associated with maternal smoking and those associated with child’s 
sex was then conducted in the NINFEA data. As data on maternal folate levels during 
pregnancy were not available in the NINFEA study, we did not identify children exposed and 
unexposed to folate to carry out the replication analyses.  
For two groups of selected CpG sites we evaluated the associations of exposure to maternal 
smoking during pregnancy and child’s sex with offspring saliva DNA methylation levels. A 
robust linear regression model was specified, and adjusted as in the discovery studies: child’s 
sex was analyzed in univariate models, while the models for maternal smoking during 
pregnancy were adjusted for maternal age, maternal education (low, medium and high) and 
parity. Batch effect was controlled by within batch matching between exposed and unexposed 
subjects. We did not adjust for cell type composition as there is no reference data set for the 
saliva cell composition and we are not aware of studies assessing performance of the 
reference free method [16] in saliva samples. We used p-values of the test of the association 
between maternal smoking or child’s sex and DNA methylation in infants. Histograms and 
quantile-quantile (QQ) plots were used to graphically evaluate the observed versus the 
expected null distribution of p-values. Deviations from the theoretical uniform distribution 
were also formally tested using the Kolmogorov-Smirnov test [17]. 
Assessment of the empirical p-value distributions 
To evaluate the impact of the increased correlation among the selected CpG sites, we assessed 
the p-value distributions under the null-hypothesis of no effects of the exposures on the 
 
 
methylation levels in the selected CpG sites. For this purpose, we generated 10,000 random 
shuffling of the exposed-unexposed status for each individual in the two datasets (maternal 
smoking during pregnancy and child’s sex) while maintaining the same ratio between exposed 
and unexposed subjects within each batch as in the original data. The associations between 
the randomly attributed exposure and methylation in the 4794 CpG sites for maternal smoking 
or 2544 CpG sites for sex were estimated in each replicate using the same linear regression 
models. P-value distributions of the 10,000 replicates were described in terms of symmetry by 
estimating the skewness and in terms of deviation from a uniform distribution by performing 
Kolmogorov-Smirnov [17,18] and Anderson-Darling tests [18–20]. To compare empirical 
distributions, we generated additional 10,000 replicates for both examples (maternal smoking 
and child’s sex) with random assignment of the exposure variables and random CpG sites 
selection. 
To ensure that the low exposure frequency in the analyses on maternal smoking did not affect 
the underlying distribution under the null hypothesis, we analyzed all NINFEA subjects with 
available EWAS data by shuffling the imaginary exposure with 69 “cases” and 69 “controls” 
and relating it to methylation levels in 4794 smoking-related CpG sites. 
Finally, to decrease the underlying correlation from both sets of CpG sites (maternal smoking 
and child’s sex) we selected only sites that have all pairwise correlation coefficients below 
0.40 in the NINFEA dataset. On these two subsets of low-correlated CpG sites associated 
with maternal smoking and child’s sex we conducted the same analyses with 10,000 randomly 
assigned exposures and for comparison randomly assigned CpG sites.  
Multiple testing correction and r-values 
Multiple comparisons correction of the NINFEA results using Benjamini-Hochberg FDR 
procedure is not appropriate for a replication study and, therefore, we used r-values [9]. R-
 
 
value is defined as the lowest FDR at which the finding can be called replicated, and with its 
modified version accounts also for the underlying dependence between the p-values within 
the primary study [9]. For each CpG site of the two datasets (maternal smoking and child’s 
sex) we computed both standard r-values for independent tests and its modified version that 
accounts for the underlying correlation. A CpG site is considered replicated if the r-value < 
0.05. For demonstration purposes we also present p-values corrected using Benjamini-
Hochberg FDR procedure [8]. 
Results 
CpG sites selection 
Of the 6073 top hits from the PACE study, 4794 (78.9%) CpG sites overlapped with those 
from the NINFEA data set. NINFEA children exposed to maternal sustained smoking during 
pregnancy (N=6, 4.3%) were matched to the unexposed children (N=30) by batch in which 
samples were analyzed, keeping a constant 1:5 ratio between exposed and unexposed 
children.  
A total of 2544 CpG sites (83.9%) were available for the replication of the results on sex 
differences and DNA methylation in newborns. The analyses were performed in 80 children, 
by choosing the maximum number of exposed children available within each batch that could 
be matched with unexposed children from the same batch to keep a constant 1:3 ratio between 
“exposed” (females, N=20) and “unexposed” (males, N=60) subjects.  
Out of the candidate CpG sites identified in the maternal plasma folate study, 344 (77.7%) 
were available in the NINFEA dataset.  
Correlation analysis 
 
 
Table 1 reports the summary statistics for the Spearman correlation coefficients calculated in 
the NINFEA data between the top CpG sites from each of the three literature datasets and for 
unselected genome-wide CpG pairs. The corresponding distributions are reported in Figure 2.  
When being pre-selected in the discovery studies, such as in the examples presented here, the 
average correlation between CpG sites tends to increase depending on the exposure under 
study. For example, the mean correlation of 0.29 between several thousands of CpG sites 
associated with maternal smoking during pregnancy was much higher than the original 
genome-wide mean correlation of 0.14. The variance of correlations in the pre-selected CpG 
sites also increased substantially compared with the genome-wide CpG sites (all p-values for 
F test <2.2x10-16, visual inspection of Figure 2).  
Replication analyses 
Figure 3 reports the p-value distributions and the QQ plots for the replication analyses of the 
top CpG sites for maternal smoking and child’s sex in the NINFEA data. For both exposures, 
there was a clear deviation of the p-value distributions and QQ plots from what would be 
expected by chance (Kolmogorov-Smirnov p-value <2.2 x 10-16 in both analyses). The 
analysis on child’s sex revealed 383 CpG sites (15.1%) with a p-value <0.05, while maternal 
smoking during pregnancy was associated with 7.8% of the analyzed CpG sites at 
conventional 5% level of significance. Based on these results, one could suggest that both the 
results for maternal smoking and the results for child’s sex are globally replicated using the 
NINFEA saliva samples. 
Assessment of the empirical p-value distributions 
In the absence of correlation, by randomly permuting and re-analyzing the data we would 
expect the p-value distribution to be approximately uniform in most of the replications. 
Distributions as those observed in Figure 3 - skewed versus lower p-values - are expected to 
 
 
be seen in a small proportion of the replications. After visual inspection of the p-value 
distribution histograms from the 10,000 random permutations of the exposure variable we 
noticed that the percentage of replications not following the uniform p-value distribution was 
much higher than the expected 5%, both in the case of pre-selected CpG sites and in the case 
of genome-wide randomly selected CpG sites.  
In fact, Kolmogorov-Smirnov p-values were low even when the p-value distribution 
histograms visually showed quite uniform patterns (see Supplemental Material; see Figure 
S1). Accordingly, as reported in Table 2, more than 90% of the replications were associated 
with a Kolmogorov-Smirnov p-value < 0.05. This proportion was higher in the case of pre-
selected than randomly selected CpG sites. The Anderson-Darling test, considered more 
sensitive to the tails of a distribution than the Kolmogorov-Smirnov test [20], gave similar 
results (data not shown). However, it should be considered that, with large sample sizes, these 
test are likely to give strong evidence against the null hypothesis (i.e. they are able to detect 
even small departures from the theoretical distribution) [21].  
To further explore the impact of the correlation structure on the p-value distributions we 
plotted the skewness of the underlying p-value distributions from the 10,000 replications for 
each of the examples (Figure 4). Symmetric distributions, such as the uniform or normal 
distribution, have the skewness value zero, while left- or right-skewed distribution have 
positive or negative values, respectively. From Figure 4, it can be noted that in the presence 
of a higher correlation between CpG sites, such as in the examples presented here, the 
skewness of the p-value distributions has a larger variation and is shifted towards positive 
values (left-skewed distributions) compared to the distributions of genome-wide randomly 
selected CpG sites. A similar pattern was also observed when all 138 subjects were analyzed 
with CpG sites associated with maternal smoking during pregnancy (see Supplemental 
 
 
Material; see Figure S2), thus ruling out a possible impact of the small sample size in the 
example with maternal smoking during pregnancy. 
It is noteworthy that the biases that we have so far described are mainly due to the underlying 
correlation structure. For demonstration purposes we have selected 256 out of 4794 CpG sites 
related to maternal smoking during pregnancy and 129 out of 2544 CpG sites related to 
child’s sex that have all pairwise correlation coefficients below an arbitrary level of 0.40 in 
the NINFEA dataset. Mean correlation coefficient was 0.09 for both low-correlated data sets, 
and thus lower than the underlying genome-wide mean correlation of 0.14.  
P-value distributions of the 10,000 random permutations of the exposure variables were 
“uniform” in 15.8% permutations of maternal smoking and 5.3% permutations of child’s sex 
according to Kolmogorov-Smirnov test. The average skewness was 0.04 for maternal 
smoking and 0.004 for child’s sex, with standard deviations much smaller than that for 
genome-wide randomly selected CpG sites (Figure 5). The results were similar when 
analyses on 256 CpG sites associated with maternal smoking were performed in all 138 
subjects from the NINFEA data (see Supplemental Material; see Figure S3). 
Multiple testing correction and r-values for replicability 
After the initial replication performed in Step 2 (Figure 1, Figure 3) a standard naïve and 
incorrect practice would then be to consider the results of the single CpG sites, after 
implementing some of the procedures that take into account multiple testing and reduce the 
number of false positives, such as Benjamini-Hochberg FDR multiple testing correction. 
After the Benjamini-Hochberg correction at the 0.05 FDR level only five CpG sites were 
selected for sex differences in methylation levels, while no CpG site remained associated with 
maternal smoking during pregnancy, reflecting the small number of exposed subjects (N=6) 
in the NINFEA dataset.  
 
 
A correct approach for a replication study would be to apply FDR-based replication p-values 
(r-values). For the analyses on sex differences in methylation levels, unmodified version of r-
value revealed 4 replicated CpG sites (all r-values=0.02), while after considering the 
underlying correlation only three sex-associated CpG sites remained replicated in the 
NINFEA cohort (all r-values=0.03). It should be noted that all CpG sites considered 
replicated according to the r-value estimates had a Benjamini-Hochberg FDR p-value <0.05, 
while two CpG sites that passed the FDR naïve correction were not replicated (Table 3). No 
CpG site was replicated for maternal smoking during pregnancy. 
Discussion 
The large number of tests performed in epigenome-wide association studies requires 
statistical and computational methods to control for multiple testing both in the exploratory 
and in the replication phase. The most commonly used methods dealing with this issue, such 
as Bonferroni and Benjamini-Hochberg FDR corrections, rely on the assumption of 
independence of the tests. This assumption is often violated in EWAS, as spatially related 
CpG sites are very often in similar methylation state. 
As shown in this paper, a certain degree of correlation already affects the discovery phase of 
EWAS, when analyses are carried out at the genome-wide level. This underlying correlation 
structure is enhanced in large sample size studies of exposures/outcomes that broadly affect 
DNA methylation, in which thousands of candidate CpG sites are selected for replication. The 
increase in correlation can be substantial: in one of the examples that we evaluated in this 
paper the mean pair-wise correlation coefficient increased from 0.14 at the genome-wide level 
to 0.29 among the selected CpG sites. Thus, the independency assumption of standard 
multiple testing procedures can be seriously violated, resulting in spurious replication 
findings. It should be noted that we analyzed the correlation structure and its impact on the 
results using only one dataset with saliva DNA methylation measured in children at 
 
 
approximately 6 months of age. Average correlation at genome-wide level and that of pre-
selected CpG sites might be different in other data sets, populations, age groups or 
tissues/biofluids. 
We argue that in situations of high correlation it is important to explore its magnitude by 
conducting permutations in which the exposure/outcome status is randomly shuffled. The so-
called permutation procedure that empirically generates a model-free p-value is based on this 
approach, and it is robust to the data correlation – a Family-wise Error Rate (FWER) control 
procedure (i.e. a procedure to control for type I errors in the context of multiple testing) based 
on permutations was proposed in the literature [22]. The only assumption behind permutation 
procedures is that the observations are exchangeable under the null hypothesis [22], while the 
most important limitation is the long computational time, especially in large EWAS. Several 
alternatives that account for the underlying correlation structure have been proposed and are 
shown to be as efficient as the permutation procedure [23–27]. The implementation of these 
approaches requires much less time, but to our knowledge, they are seldom used in the 
analysis of EWAS. Although not in the context of an increased correlation in replication 
studies, a recent study by van Iterson at al. [28] sheds light on the inflation and bias of test 
statistics in EWAS and transcriptome-wide association studies. They proposed a Bayesian 
method for the estimation of the empirical null distribution and bias and inflation correction in 
the presence of the correlated test statistics [28]. 
Several recently published EWAS used Benjamini-Hochberg FDR method to adjust for 
multiple tests, both in the discovery and replication analysis. Apart from using alternative 
methods to account for the underlying correlation, an option for the replication phase would 
be to select a subgroup of CpG sites using ad-hoc algorithms to decrease the correlation, 
including, for example, approaches based on the genomic location or the introduction of a 
maximum threshold for pairwise correlation coefficients. To our knowledge, the performance 
 
 
and validity of possible selection criteria remains to be systematically investigated in 
methodological studies. 
In this study we applied and recommended r-values as an FDR-based measure and an 
appropriate method for replication studies. The modified version of r-value guarantees false-
discovery rate control under any type of dependency between tests, and is an appropriate 
approach for the replication phase of EWAS.  
Finally, we have also shown that the Kolmogorov-Smirnov and Anderson-Darling tests, often 
used to assess departures from a uniform distribution of p-values, become extremely sensitive 
in presence of large sample sizes. Thus, if hundreds or thousands correlated CpG sites are 
selected for replication, these tests will almost invariably generate low p-values, and a 
spurious result of a global replication of the exploratory phase is very likely.  
Conclusions 
We caution against using FWER control procedures (e.g. the simple Bonferroni correction) or 
Benjamini-Hochberg FDR control in epigenome-wide replication studies, where the 
correlation between CpG sites can be substantial and the null hypothesis different than the 
null hypothesis of a discovery study. Permutation procedures are proposed as the method of 
choice to control FWER in the circumstances of highly correlated tests, but they are time-
consuming when applied to large-scale studies, and are seldom used in EWAS. In replication 
studies, CpG sites for replication could also be selected a priori, based on different criteria or 
their combinations, such as significance in the discovery sample, correlation with other CpG 
sites, genomic location or biological significance. An option that is highly recommended for 
replication studies is the computation of r-values, which focus specifically on the strength of 
replication. In the context of epigenome-wide replication studies with highly correlated tests, 
we suggest to rely on robust FDR r-value. 
 
 
 
Executive summary 
• The most commonly used approaches dealing with multiple testing in the replication 
phase of epigenome-wide association studies are type I error rate and false-discovery 
rate controls that, although claimed to be robust, assume independence between tests. 
• The correlation between CpGs is enhanced after selection during the discovery phase. 
• In the replication phase of EWAS an increased correlation between CpGs might 
translate into biased empirical p-value distributions, affecting also the usual control by 
Benjamini-Hochberg FDR procedure. 
• Benjamini-Hochberg FDR method might not be adequate for the replication phase of 
EWAS. 
• Replication studies should consider methods that take into account the underlying 
correlation structure, including permutation procedures and r-values to detect 
replicated associations. 
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Table 1. Summary statistics of the correlation coefficients’ distributions, expressed as 
absolute values, in 138 children of the NINFEA cohort. 
Set of CpG sites N 3
rd 
percentile
Mean Median 97
th 
percentile
Genome-wide 321084 0.01 0.14 0.10 0.49
Maternal plasma folate study 344 0.01 0.15 0.11 0.46
Child’s sex 2544 0.01 0.19 0.14 0.59
Maternal smoking during pregnancy 4794 0.01 0.29 0.24 0.76
 
 
Table 2. Kolmogorov-Smirnov test assessing the uniformity of the p-value distributions from 
10,000 permutations  
Permutations 
(N=10,000) 
Percentage of permutations 
associated with a Kolmogorov-
Smirnova p-value < 0.05 (%) 
Maternal smoking during pregnancy 96.4 
Random CpG sites 93.0 
Child’s sex 95.9 
Random CpG sites 93.8 
a Kolmogorov-Smirnov test to determine if the distribution of p-values from 
each replication is equal to the expected uniform distribution. 
 
 
 
 
 
 
Table 3. Sex-associated CpG sites that passed Benjamini-Hochberg (BH) FDR correction and 
corresponding uncorrected p-values, BH FDR p-values and FDR r-values 
CpG sites Discovery study p-
value 
Replication study 
p-value
BH FDR 
p-value
FDR  
r-valuea 
Modified 
r-valueb
cg25438440 1.86e-18 1.81e-05 0.02 0.02 0.03
cg19544707 4.06e-12 9.77e-06 0.02 0.02 0.03
cg03168896 9.30e-09 1.53e-05 0.02 0.02 0.03
cg12763978 5.65e-07 1.40e-05 0.02 0.02 0.23
cg14022202 5.85e-06 2.89e-05 0.02 0.14 0.40
a R-value for the independent tests 
b Conservative modification of r-value that accounts for any type of the dependency between tests  
 
Figure 1. The main steps of the analysis 
 
Figure 2. Distribution of correlation coefficients (left side) and their absolute values with the 
corresponding absolute mean correlation coefficients (right side) for genome-wide CpG sites, 
 
 
4794 CpG sites associated with maternal smoking during pregnancy, 344 CpG sites 
associated with maternal folate levels and 2544 CpG sites associated with child’s sex.  
 
Figure 3. Distribution of replication p-values and QQ plot of observed versus expected p-
values testing the null hypotheses of no association between methylation levels of pre-
selected CpG sites and maternal smoking during pregnancy, and child’s sex. 
 
 
 
Figure 4. Skewness of p-value distributions from the analyses of the association between 
smoking-related and sex-related CpG sites and permutations of maternal smoking during 
pregnancy and child’s sex from 10,000 replications. “Random” indicates random 
permutations of both CpG sites and exposure under study.  
 
Figure 5. Skewness of p-value distributions from the analyses of the association between pre-
selected low-correlated CpG sites and permutations of maternal smoking/child’s sex from 
 
 
10,000 replications. “Random” indicates random permutations of both CpG sites and 
exposure under study.  
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Figure S1. Histograms of p-value distributions from random permutations and Kolmogorov-
Smirnov p value assessing whether the observed p-value distributions come from a 
hypothesized uniform distribution 
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Figure S2. Skewness of p-value distributions from the analyses of the association between 
4794 CpG sites associated with maternal smoking and 10,000 permutations of an imaginary 
exposure for 138 subjects from the NINFEA cohort. “Random” indicates random 
permutations of both CpG sites and exposure under study. 
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Figure S3. Skewness of p-value distributions from the analyses of the association between 256 low-
correlated CpG sites associated with maternal smoking and 10,000 random permutations of an 
imaginary exposure for 138 subjects from the NINFEA cohort. “Random” indicates random 
permutations of both CpG sites and exposure under study.  
 
